Hawaii 2024 Regular Session

Hawaii Senate Bill SB2119

Introduced
1/17/24  
Refer
1/18/24  
Introduced
1/17/24  
Report Pass
2/15/24  
Refer
1/18/24  
Report Pass
2/15/24  
Report Pass
2/29/24  
Refer
2/15/24  
Engrossed
3/1/24  
Report Pass
2/29/24  
Engrossed
3/1/24  
Refer
3/7/24  
Refer
3/7/24  
Report Pass
3/28/24  
Report Pass
3/28/24  
Report Pass
4/25/24  
Report Pass
4/25/24  
Report Pass
4/25/24  
Enrolled
5/1/24  
Enrolled
5/1/24  
Chaptered
6/28/24  
Chaptered
6/28/24  

Caption

Relating To Out-of-state Prescriptions.

Impact

The proposed amendments to Section 328-17.6 of the Hawaii Revised Statutes would allow out-of-state pharmacies to transfer not only prescription information for refills but also for the initial fill, thereby making it easier for patients visiting Hawaii to obtain necessary medications. If enacted, this legislation would facilitate a more efficient healthcare delivery system, particularly for individuals requiring acute medications during their temporary stay in the state. The inclusion of provisions ensuring appropriate record keeping is intended to maintain the integrity and safety of prescription practices across state lines.

Summary

Senate Bill 2119 aims to improve the process for out-of-state patients requiring medication while in Hawaii by authorizing out-of-state pharmacies to transfer prescription information for the initial fill of out-of-state prescriptions. Currently, Hawaii law does not permit out-of-state pharmacies to transfer this information directly to in-state pharmacies, which leads to delays as local pharmacists need to contact the out-of-state practitioners for verbal orders. This bill seeks to streamline the process, reducing administrative burdens and improving timely access to necessary prescriptions for out-of-state patients.

Sentiment

The sentiment surrounding SB2119 appears to be generally positive, particularly among lawmakers and healthcare professionals who recognize the importance of ensuring that patients have access to medications without unnecessary delays. Supporters advocate for the convenience this legislation will provide to traveling patients and the healthcare system as a whole. However, it is essential to note that concerns from various stakeholders regarding the implications for drug safety and the need for careful tracking of transferred prescriptions are likely to be part of ongoing discussions during the legislative process.

Contention

While there seems to be strong support for the bill, some contention may arise regarding the regulatory oversight necessary to ensure that the transfer process maintains high safety standards. This includes ensuring that patients are adequately informed of the status of their prescriptions and that proper records are kept meticulously. Also, stakeholders may raise questions about the potential impacts on the in-state pharmacy operations and whether such changes could affect local pharmacies' ability to compete with out-of-state pharmacies.

Companion Bills

HI HB1825

Same As Relating To Out-of-state Prescriptions.

Previously Filed As

HI HB1825

Relating To Out-of-state Prescriptions.

HI HB872

Relating To Health.

HI SB594

Relating to the regulation of prescriptions for controlled substances, including certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

HI SB195

Relating to prescriptions for certain controlled substances, access to information about those prescriptions, and the duties of prescribers and other entities registered with the Federal Drug Enforcement Administration; authorizing fees.

HI SB1233

Relating to controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.

HI SB542

Relating to the prescription and pharmaceutical substitution of biological products.

HI HB102

Prescriptions; off-label use.

HI SB190

Relating to the prescription and pharmaceutical substitution of biological products.

HI HB2766

Relating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.

HI HB2174

Relating to controlled substance prescriptions and reimbursement for treatment for certain substance use disorders; authorizing a fee.

Similar Bills

CA AB852

Health care practitioners: electronic prescriptions.

HI HB1825

Relating To Out-of-state Prescriptions.

CA AB2789

Health care practitioners: prescriptions: electronic data transmission.

LA HB548

Requires that the prescribers transmit prescriptions for opioids to pharmacies electronically (EG SEE FISC NOTE SG EX See Note)

CT SB00135

An Act Concerning Revisions To Pharmacy And Drug Control Statutes.

NJ S3388

Allows pharmacists to transfer Schedule II attention-deficit/hyperactivity disorder prescriptions.

NJ A4391

Allows pharmacists to transfer Schedule II attention-deficit/hyperactivity disorder prescriptions.

OK SB638

Pharmacy; modifying program for utilization of unused prescription drugs; providing for return of drugs to pharmacy for credit or reimbursement. Effective date.